Linvemastat

Linvemastat
Clinical data
Other namesFP-020
Identifiers
  • 5-[3-[4-[(2-methyl-4-pyridinyl)methoxy]phenyl]sulfanylfuran-2-yl]imidazolidine-2,4-dione
CAS Number
PubChem CID
ChemSpider
ChEMBL
Chemical and physical data
FormulaC20H17N3O4S
Molar mass395.43 g·mol−1
3D model (JSmol)
  • CC1=NC=CC(=C1)COC2=CC=C(C=C2)SC3=C(OC=C3)C4C(=O)NC(=O)N4
  • InChI=InChI=1S/C20H17N3O4S/c1-12-10-13(6-8-21-12)11-27-14-2-4-15(5-3-14)28-16-7-9-26-18(16)17-19(24)23-20(25)22-17/h2-10,17H,11H2,1H3,(H2,22,23,24,25)
  • Key:GUKPADSDFUIAMC-UHFFFAOYSA-N

Linvemastat is an investigational new drug that is being evaluated by Foresee Pharmaceuticals for the treatment of Asthma. It is a matrix metalloproteinase 12 inhibitor.